US Stock MarketDetailed Quotes

LGND Ligand Pharmaceuticals

Watchlist
  • 84.070
  • -3.210-3.68%
Close May 13 16:00 ET
  • 84.070
  • 0.0000.00%
Post 16:20 ET
1.51BMarket Cap15.68P/E (TTM)

Ligand Pharmaceuticals Key Stats

Ligand Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

30.98M

-29.56%
EPS(YoY)

4.75

+103.86%

Strong Buy

May 8, 2024

Ligand Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 35.539M--
--2024/Q2-- / 32.823M--
May 7, 20242024/Q130.978M / 27.924M--
Feb 27, 20242023/Q428.101M / 25.645M--
Nov 8, 20232023/Q332.868M / 27.224M--
Aug 8, 20232023/Q226.366M / 25.733M--
May 4, 20232023/Q143.979M / 33.547M--
Feb 22, 20232022/Q450.382M / 39.635M--
Nov 7, 20222022/Q366.088M / 38.332M--
Aug 8, 20222022/Q257.419M / 37.735M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 35.539M--
--2024/Q2-- / 32.823M--
May 7, 20242024/Q130.978M / 27.924M--
Feb 27, 20242023/Q428.101M / 25.645M--
Nov 8, 20232023/Q332.868M / 27.224M--
Aug 8, 20232023/Q226.366M / 25.733M--
May 4, 20232023/Q143.979M / 33.547M--
Feb 22, 20232022/Q450.382M / 39.635M--
Nov 7, 20222022/Q366.088M / 38.332M--
Aug 8, 20222022/Q257.419M / 37.735M--

Unlock Free Earnings Estimates

Ligand Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 8, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg